The efficacy AUC value of CDCA2 as a diagnostic marker for HCC was 0.925 (Supplementary Figure S2), and CDA2 was also shown to be significantly associated with HCC prognosis (p < 0.001) (Figure 5K). This evidence concerns the gene CDCA2 and hepatocellular carcinoma.